The loss of SurModics under GAAP for 3 months of fiscal year 2022 was $2.812 million, up 10.3 times from $0.274 million in the previous year. Revenue increased 3.2% to $23.003 million from $22.297 million a year earlier.
The loss of SurModics under GAAP for 3 months of fiscal year 2022 was $2.812 million, up 10.3 times from $0.274 million in the previous year. Revenue increased 3.2% to $23.003 million from $22.297 million a year earlier. 
surmodics.gcs-web.com
English (US) 